SGI announced this morning that the Institute of Cancer Research [ICR] selected their Altix UV for their next computational platform. The new scalable shared memory system will provide compute for research in biological networking, MRI imaging, mass-spectrometry, phenotyping, genetics and deep-sequencing.
The Altix UV supercomputer will allow extremely large, diverse data sets to be processed quickly, enabling our researchers to correlate medical and biological data on an unprecedented scale,” said Dr. Rune Linding, cellular and molecular logic team leader at the ICR. “Eventually, this will lead to network-based cancer models that will be used to streamline the process of drug development.”
The Nehalem-EX-based system will support up to 16 terabytes of globally shared memory in a single system image [OS].
Altix UV will allow HPC customers like the ICR to think differently and solve problems that cannot be solved on other HPC platforms,” said Rod Evans, vice president of sales for Northern Europe at SGI. “We are delighted to be working with the ICR to provide this unique technology required to process the huge amounts of cancer-related data generated in medical research.”
For more info, read their full release here.